Robert E. Mosser

Array ( [id] => 6202966 [patent_doc_number] => 20110065752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'METHODS OF TREATING ORTHOMYXOVIRAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/873704 [patent_app_country] => US [patent_app_date] => 2010-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6253 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065752.pdf [firstpage_image] =>[orig_patent_app_number] => 12873704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6613789 [patent_doc_number] => 20100310477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Pharmaceutical compositions based on anticholingerics and additional active ingredients' [patent_app_type] => utility [patent_app_number] => 12/855825 [patent_app_country] => US [patent_app_date] => 2010-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 37405 [patent_no_of_claims] => 238 [patent_no_of_ind_claims] => 49 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310477.pdf [firstpage_image] =>[orig_patent_app_number] => 12855825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6163375 [patent_doc_number] => 20110160254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'COMBINATION OF A BIS-THIAZOLIUM SALT OR A PRECURSOR THEREOF AND ARTEMISININ OR A DERIVATIVE THEREOF FOR TREATING ACUTE MALARIA' [patent_app_type] => utility [patent_app_number] => 12/851747 [patent_app_country] => US [patent_app_date] => 2010-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6253 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160254.pdf [firstpage_image] =>[orig_patent_app_number] => 12851747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8712885 [patent_doc_number] => 08399023 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Crystallization method and bioavailability' [patent_app_type] => utility [patent_app_number] => 12/847568 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 10820 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12847568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11886771 [patent_doc_number] => 09757318 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-12 [patent_title] => 'Process for relaxing keratin fibres' [patent_app_type] => utility [patent_app_number] => 12/841482 [patent_app_country] => US [patent_app_date] => 2010-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5827 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12841482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212355 [patent_doc_number] => 20110135655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'Role of PI3K p110 delta Signaling in Retroviral Infection and Replication' [patent_app_type] => utility [patent_app_number] => 12/835474 [patent_app_country] => US [patent_app_date] => 2010-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 26192 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135655.pdf [firstpage_image] =>[orig_patent_app_number] => 12835474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186856 [patent_doc_number] => 20120115912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'RXR AGONIST COMPOUNDS AND METHODS' [patent_app_type] => utility [patent_app_number] => 13/383131 [patent_app_country] => US [patent_app_date] => 2010-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 25382 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115912.pdf [firstpage_image] =>[orig_patent_app_number] => 13383131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8312590 [patent_doc_number] => 20120189614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'INHIBITORS OF FILOVIRUS ENTRY INTO HOST CELLS' [patent_app_type] => utility [patent_app_number] => 13/383345 [patent_app_country] => US [patent_app_date] => 2010-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19387 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199414 [patent_doc_number] => 20120122877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'Compositions for Treating Bacterial Infections' [patent_app_type] => utility [patent_app_number] => 13/379784 [patent_app_country] => US [patent_app_date] => 2010-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4150 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122877.pdf [firstpage_image] =>[orig_patent_app_number] => 13379784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6352869 [patent_doc_number] => 20100331409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'Use of Methyl Cinnamate in the Inhibition of Candida Albicans Biofilms' [patent_app_type] => utility [patent_app_number] => 12/821497 [patent_app_country] => US [patent_app_date] => 2010-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3256 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331409.pdf [firstpage_image] =>[orig_patent_app_number] => 12821497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6167923 [patent_doc_number] => 20110196028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'PCK ACTIVATION AS A MEANS FOR ENHANCING sAPPa SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/817642 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12114 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20110196028.pdf [firstpage_image] =>[orig_patent_app_number] => 12817642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8289271 [patent_doc_number] => 20120177601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'TREATMENT OF HEPATITIS C VIRUS INFECTIONS' [patent_app_type] => utility [patent_app_number] => 13/381548 [patent_app_country] => US [patent_app_date] => 2010-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15822 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13381548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043633 [patent_doc_number] => 20120071549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'ANTI-INFLAMMATORY COMPOSITION CONTAINING MACROLACTIN A AND A DERIVATIVE THEREOF AS ACTIVE INGREDIENTS' [patent_app_type] => utility [patent_app_number] => 13/321112 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6401 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071549.pdf [firstpage_image] =>[orig_patent_app_number] => 13321112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11296681 [patent_doc_number] => 09504673 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-29 [patent_title] => 'Agent for the prophylaxis and treatment of highly pathogenic infectious diseases' [patent_app_type] => utility [patent_app_number] => 13/320724 [patent_app_country] => US [patent_app_date] => 2010-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3253 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15052187 [patent_doc_number] => 10456369 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-29 [patent_title] => Methods and compositions for improving the health of animals [patent_app_type] => utility [patent_app_number] => 13/318236 [patent_app_country] => US [patent_app_date] => 2010-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 7512 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13318236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8406498 [patent_doc_number] => 20120238566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'USE OF CELL AUTOPHAGY (TYPE II CELL APOPTOSIS) INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/265692 [patent_app_country] => US [patent_app_date] => 2010-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 30003 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13265692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784806 [patent_doc_number] => 20120046362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'ANTIVIRAL AGENT AND CLEANSING AGENT' [patent_app_type] => utility [patent_app_number] => 13/264934 [patent_app_country] => US [patent_app_date] => 2010-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9969 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046362.pdf [firstpage_image] =>[orig_patent_app_number] => 13264934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321082 [patent_doc_number] => 20100196508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'METHOD AND COMPOSITION FOR SUPPLEMENTATION OF NUTRITIONAL DEFICIENCIES IN RENAL PATIENTS' [patent_app_type] => utility [patent_app_number] => 12/758333 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8078 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196508.pdf [firstpage_image] =>[orig_patent_app_number] => 12758333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6328527 [patent_doc_number] => 20100197782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'THERAPEUTIC AGENT FOR VIRUS-ASSOCIATED MALIGNANCY' [patent_app_type] => utility [patent_app_number] => 12/755150 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3305 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197782.pdf [firstpage_image] =>[orig_patent_app_number] => 12755150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9749827 [patent_doc_number] => 08841302 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'HCV inhibitor and therapeutic agent combinations' [patent_app_type] => utility [patent_app_number] => 13/259386 [patent_app_country] => US [patent_app_date] => 2010-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45549 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13259386 [rel_patent_id] =>[rel_patent_doc_number] =>)